Hepatitis A vaccine
واکسن هپاتیت A
🦠 Antiinfectives For Systemic UseInactivated vaccine
Market / country: 🇺🇸 USA
Havrix (US)
🧮 Dose calculator
Immunisation (vaccination) · Regimen source: FDA Havrix · 2.3
- • At least 2 weeks before expected exposure. IM, not in the buttock. FDA Havrix · 1FDA Havrix · 2.2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Anaphylaxis to a previous hepatitis A vaccine dose or a component (including neomycin). FDA Havrix · 4
Formulations
- 0.5 mL (child) or 1 mL (adult) — injection 🇺🇸 USA FDA Havrix · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label: available data do not suggest an increased risk of major birth defects or miscarriage; no adequate controlled studies. FDA Havrix · 8.1
“Available data do not suggest an increased risk of major birth defects and miscarriage in women who received HAVRIX during pregnancy”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Havrix · 8.2
“Risk Summary There is no information regarding the presence of HAVRIX in human milk, the effects on the breastfed child, or the effects on milk production.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Havrix · 8.4
“The safety and effectiveness of HAVRIX have not been established in pediatric patients younger than 12 months.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Havrix · 8.5
“Clinical studies of HAVRIX did not include sufficient numbers of participants aged 65 years and older to determine whether they respond differently from younger participants.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)BLA103475
- DailyMed (FDA label)FDA Havrix
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDJ07BC02
- Darooyab (Iran)Hepatitis-A-Vaccines
🇮🇷 Registered in Iran Darooyab · G-3467/Hepatitis-A-Vaccines
Dosage forms with Iranian generic codes, per Darooyab.
- 51974 · HEPATITIS A, INACTIVATED, WHOLE VIRUS INJECTION, SUSPENSION PARENTERAL 50 [iU]/1mL · سوسپانسیون تزریقی هپاتیت A غیرفعالشده کامل ویروس ۵۰ واحد بینالمللی / ۱ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Havrix · 3FDA Havrix · 2.3FDA Havrix · 1FDA Havrix · 2.2FDA Havrix · 4FDA Havrix · 8.1FDA Havrix · 8.2FDA Havrix · 8.4FDA Havrix · 8.5FDA Havrix · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-3467/Hepatitis-A-Vaccines
- Clinical review⚠ Unverified